Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Dec 1, 2023
- Accession no.
- 0001447362-23-000159
- Filed
- Dec 1, 2023
- Trade date
- Nov 29-30, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions. Open-market sales total $430.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Common Stock | SSaleDisposed | −5,743 | $20.13F2 | −$115,606.59 | 106,389 | Direct | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −1,811 | $20.13F2 | −$36,455.43 | 103,105 | Indirect | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −1,811 | $20.13F2 | −$36,455.43 | 92,000 | Indirect | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −659 | $20.13F2 | −$13,265.67 | 15,651 | Indirect | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −660 | $20.13F2 | −$13,285.8 | 15,651 | Indirect | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −660 | $20.13F2 | −$13,285.8 | 15,652 | Indirect | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −660 | $20.13F2 | −$13,285.8 | 15,645 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −4,510 | $20.07F9 | −$90,515.7 | 101,879 | Direct | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −1,421 | $20.07F9 | −$28,519.47 | 101,684 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −1,421 | $20.07F9 | −$28,519.47 | 90,579 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −519 | $20.07F9 | −$10,416.33 | 15,132 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −518 | $20.07F9 | −$10,396.26 | 15,133 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −518 | $20.07F9 | −$10,396.26 | 15,134 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −518 | $20.07F9 | −$10,396.26 | 15,127 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.03 to $20.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $20.00 to $20.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.